Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled, ‘Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital) – Global Forecast to 2031’
According to this latest publication from Meticulous Research®, the global protein assays market is projected to reach $4.36 billion by 2031 at a CAGR of 9.3% from 2024 to 2031. The growth of this market can be attributed to various factors, such as increasing pharmaceutical R&D expenditure, rising use of protein assays in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests. However, the high cost of protein assay equipment restrains market growth.
Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities. However, the shortage of skilled professionals and high chances of error with complex samples are a major challenge for the market’s growth.
Key Players
The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.).
Protein Assays Market: Future Outlook
The global protein assays market is segmented by Offering (Reagents & Kits and Instruments & Accessories), Type (Dye-based Assay, Copper-based Assay, and Other Assay Types), Technology (Fluorescence-based Protein Assay, Absorbance-based Protein Assay, and Colorimetric-based Protein Assay), Application (Drug Discovery, Research & Development, Clinical Diagnosis, and Other Applications), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Food & Beverage Companies, Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.
Among all the offerings studied in this report, in 2024, the reagents & kits segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the increasing use of protein assays reagents & kits for accurate and faster results. Additionally, the wide availability of consumables, recurring use of protein assay kits, and increasing adoption of these kits by researchers to estimate protein concentration in unknown samples are contributing to the largest share of the segment.
Among all the types studied in this report, in 2024, the dye-based assay segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the rapid results with the dye-based assays enabling testing of a high number of samples in a short time, and the test uses visible light for the detection, so no special instrumentation is required. Additionally, the reagents used in the assays do not cross-react with each other thus, the reliability of the method increases, and increasing use of dye-binding assays in the determination of residual protein content in biological processes such as cell lysis is contributing to the largest share of the segment.
Among all the technologies studied in this report, in 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the absorbance method is an accepted choice for researchers, has less sample consumption, is simple to perform, and requires no additional or hazardous reagents or standards. Additionally, absorbance is considered the best measurement method for the quantification of pure protein samples, further supporting the largest share of the segment.
Among all the applications studied in this report, in 2024, the drug discovery segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the increased use of protein assay in life science research, as quantification of proteins is a primary requirement for many downstream processes such as structural analysis, immunochemical techniques, protein separation, and chromatographic techniques, which can further be employed into drug discovery & development process.
Among all end users studied in this report, in 2024, the pharmaceutical & biotechnology segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the growing number of research and clinical laboratories, increased investments in R&D, and rising funding for pharmaceutical research. The rising demand for new drugs and therapies is driving an increase in funding for research laboratories, consequently creating a higher demand for protein assays. For instance, NIH funding has witnessed an increase from USD 42 billion in 2021 to USD 45 billion in 2022 for research purposes (Source: Congressional Research Service).
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa.
Among all regions studied in this report, in 2024, North America is expected to account for the largest share of the protein assays market. North America’s major market share is attributed to the presence of key players, well-established research and clinical laboratories, and substantial spending on R&D by pharmaceutical and biotechnology companies. Additionally, the expansion of research and clinical laboratories by the key players is supporting the largest regional share. For instance, in October 2022, Thermo Fisher Scientific Inc. (U.S.) is expanding its clinical research lab in Kentucky, U.S., with an investment of USD 59 million.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5803
Key questions answered in the report-
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Bakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More